HJLI Stock Price, News & Analysis

HJLI

Company Description

HJLI (Nasdaq: HJLI) is a publicly traded company.

HJLI stock has gained 2297.2% over the past year.

This page provides a comprehensive overview of HJLI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+2297.23%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

HJLI (HJLI) stock. Over the past 12 months, the stock has gained 2297.2%.

Latest News

View All

October 1, 2021

—

enVVeno Medical Corporation Successfully Completes Rebranding

September 24, 2021

+2.90%

Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann

conferences

September 21, 2021

-1.98%

Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs

September 15, 2021

+5.13%

Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021

conferences

September 7, 2021

+0.62%

Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

offering

August 19, 2021

-8.58%

Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society for Vascular Surgery Annual Meeting

HJLI has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, offering, fda approval. View all HJLI news →

SEC Filings

View All

No SEC filings available for HJLI.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months